Company intelligence / Profile preview

Stoic Venture Capital

Sydney, New South Wales, Australiastoicam.com.au ↗
Ownership
Private
Development stage
Phase 2
01

Overview

Stoic Venture Capital is an Australian venture fund investing in emerging science and frontier technologies at the seed and pre-seed stage. Their life science/biotech investments include therapeutics for systemic sclerosis (Certa Therapeutics – FT011 in Phase 2 with positive results), respiratory viral infection prevention (ENA Respiratory – lead candidate in Phase 2 showing reduced duration of influenza A infection), precision oncology surgery/imaging/therapy (Ferronova), novel therapies for psychiatric disorders/substance use disorder (Kinoxis Therapeutics). They have supported at least four exits and have a track record of successful fundraising rounds for their portfolio companies.

Therapeutic areas
OncologyEndocrinologyPsychiatryRheumatologyInfectious Diseases
Modalities
Small moleculeBiologicMonoclonal antibodyDeviceDigital health platforms
Industry
Investors
02

Drug pipeline

2 assets

asengeprast

Phase 2
Indications
Systemic sclerosis

1 more asset in the full pipeline.

Request access →
03

Partnerships

Boehringer Ingelheim licensing deal with Kinoxis Therapeutics (~$300M value)other partnerships via investee collaborations

Beyond the preview

Go deeper on Stoic Venture Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stoic Venture Capital.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call